MedPath

Influence of Muscle Relaxation With Rocuronium Bromide During General Anaesthesia on Muscle Trauma and Postoperative Analgetic Consumption in Patients With Total Hip Prosthesis Implantation

Phase 4
Completed
Conditions
Muscle Relaxation
Muscle Trauma
Analgetic Consumption
Total Hip Replacement
Interventions
Procedure: effect of muscle relaxation on muscle trauma, control group without relaxation
Registration Number
NCT01228162
Lead Sponsor
Klinikum Hildesheim GmbH
Brief Summary

The researchers want to investigate the effects of muscle relaxation with rocuronium bromide during general anaesthesia on muscle trauma (serum CK, CRP) and postoperative analgesic consumption in patients with total hip prosthesis replacement (general vs. spinal anaesthesia).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  1. patient agreement
  2. indication for total hip replacement
  3. age 55 - 80 years
  4. weight 65 - 95 kg
  5. first intervention
  6. ASA classification I - III
  7. general and spinal anaesthesia possible in this patient
Exclusion Criteria

a) neuromuscular diseases b) surgery with muscle trauma (within the last 3 months) c) permanent immobility d) intramuscular injections (within the last 4 weeks) e) medication with opioids f) medication with co-analgetics g) contraindications for general or spinal anaesthesia h) dementia, cognitive dysfunction or sleep apnea

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
general anaesthesiaeffect of muscle relaxation on muscle trauma, control group without relaxationpatients receiving general anaesthesia and rocuronium bromide for muscle relaxation
spinal anaesthesiaeffect of muscle relaxation on muscle trauma, control group without relaxationpatients receiving spinal anaesthesia without muscle relaxation
Primary Outcome Measures
NameTimeMethod
degree of muscle trauma24 hours

serum CK and CRP levels are measured

Secondary Outcome Measures
NameTimeMethod
consumption of analgetics3 days

consumption of piritramide is measured

Trial Locations

Locations (1)

Klinikum Hildesheim GmbH

🇩🇪

Hildesheim, Germany

© Copyright 2025. All Rights Reserved by MedPath